Five Oceans Advisors »

Vertex Pharmaceuticals Incorporated shares owned by Five Oceans Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Five Oceans Advisors from 13F filings

Historical chart of Five Oceans Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Five Oceans Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Five Oceans Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $236k 565 418.01
2023-12-31 $230k 565 406.89

More positions owned by Five Oceans Advisors

Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Emerging Markets (DFSE)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Inflation Prote (DFIP)
Apple (AAPL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust International (DFSI)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds Total Stk Mkt (VTI)
Meta Platforms Cl A (META)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Novo-nordisk A S Adr (NVO)

View all positions for Five Oceans Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated